Our Research

The NIHR Birmingham Biomedical Research Centre in Inflammation is building on our established world-class strengths in inflammation biology and experimental medicine, and is accelerating access to and adoption of new therapies and diagnostic tests for patients with chronic immune-mediated inflammatory diseases (IMIDs).

The NIHR Birmingham Biomedical Research Centre has brought together three globally recognised and nationally funded research themes in inflammatory arthritis, inflammatory bowel disease and inflammatory sarcopenia and has created a first in class process-driven, pathway-focused approach to the study and management of inflammatory diseases.

Inflammatory Arthritis

Inflammatory arthritis is a group of diseases characterized by inflammation of the joints and often other tissues. Professor Christopher Buckley

Inflammatory Gastroenterology

Inflammatory Gastroenterology is a debilitating condition resulting from inflammation in the intestinal tract, affecting approximately 1 in every 250 people…

Inflammatory Sarcopenia

In many chronic inflammatory diseases, including Rheumatoid Arthritis, Inflammatory Bowel Disease and liver disease, loss of muscle mass and strength

Critical to the success of the three main research themes is our cross-cutting themes on Trial Design and Delivery, Devices and Diagnostic Tests and Entrepreneurship and Commercialisation.

Trial Design and Delivery

The over-arching strategy of the Trial Design and Delivery theme, led by Professor Philip Newsome, is to focus on…

Diagnostics and Biomarkers

Advances in experimental medicine increasingly rely on the development of diagnostic devices, novel biomarkers, repurposing of existing tests, and identifying…

Entrepreneurship and Commercialisation

The Entrepreneurship and Commercialisation cross-cutting theme, led by Professor David Wraith, has established a commercially-aware and responsive environment for researchers